GTCR, a leading private equity firm, announced Wednesday that it has made a strategic, majority investment in Biocoat Holdings, LLC (“Biocoat” or the “Company”). Founded in 1991 and headquartered in Horsham, Pennsylvania, Biocoat is a leading medical device contract manufacturing organization (“CMO”), specializing in custom, biocompatible hydrophilic coatings for interventional medical devices. The Company’s capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions.
Read the full article: GTCR Announces Investment in Biocoat //
Source: https://www.prnewswire.com/news-releases/gtcr-announces-investment-in-biocoat-301665671.html